Sofinnova Investments as of June 30, 2023
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 48 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 19.6 | $300M | 1.4M | 216.85 | |
| Natera (NTRA) | 9.9 | $151M | 3.1M | 48.66 | |
| AstraZeneca Sponsored Adr (AZN) | 8.0 | $122M | 1.7M | 71.57 | |
| Intuitive Surgical (ISRG) | 4.5 | $69M | 201k | 341.94 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 4.4 | $67M | 754k | 89.25 | |
| Aerovate Therapeutics (AVTE) | 4.2 | $65M | 3.8M | 17.15 | |
| Merck & Co (MRK) | 4.0 | $61M | 527k | 115.39 | |
| Vera Therapeutics Cl A (VERA) | 3.6 | $56M | 3.5M | 16.05 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.3 | $51M | 145k | 351.91 | |
| Exelixis (EXEL) | 3.2 | $49M | 2.6M | 19.11 | |
| Dex (DXCM) | 3.1 | $48M | 371k | 128.51 | |
| IDEXX Laboratories (IDXX) | 2.3 | $36M | 71k | 502.23 | |
| Immatics NV SHS (IMTX) | 2.3 | $35M | 3.0M | 11.54 | |
| Syndax Pharmaceuticals (SNDX) | 2.2 | $33M | 1.6M | 20.93 | |
| Boston Scientific Corporation (BSX) | 2.2 | $33M | 609k | 54.09 | |
| Reata Pharmaceuticals Cl A | 2.2 | $33M | 323k | 101.96 | |
| Cytokinetics (CYTK) | 1.8 | $28M | 843k | 32.62 | |
| Inhibrx | 1.7 | $26M | 998k | 25.96 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $23M | 828k | 28.21 | |
| Inozyme Pharma (INZY) | 1.3 | $20M | 3.7M | 5.57 | |
| Vir Biotechnology Put Option (VIR) | 1.3 | $19M | 788k | 24.53 | |
| Geron Corporation (GERN) | 1.1 | $17M | 5.4M | 3.21 | |
| Baxter International (BAX) | 1.1 | $17M | 362k | 45.56 | |
| Ideaya Biosciences (IDYA) | 1.0 | $16M | 665k | 23.50 | |
| ImmunoGen | 1.0 | $16M | 827k | 18.87 | |
| argenx SE Sponsored Adr (ARGX) | 1.0 | $16M | 40k | 389.73 | |
| Y Mabs Therapeutics | 1.0 | $15M | 2.2M | 6.79 | |
| Revolution Medicines (RVMD) | 0.9 | $14M | 520k | 26.75 | |
| Axsome Therapeutics (AXSM) | 0.8 | $13M | 179k | 71.86 | |
| Marinus Pharmaceuticals Call Option | 0.8 | $13M | 1.2M | 10.86 | |
| Ptc Therapeutics I (PTCT) | 0.7 | $11M | 260k | 40.67 | |
| Galera Therapeutics (GRTX) | 0.6 | $9.6M | 3.1M | 3.12 | |
| Replimune Group (REPL) | 0.5 | $8.1M | 349k | 23.22 | |
| Agenus | 0.5 | $7.9M | 4.9M | 1.60 | |
| Celldex Therapeutics (CLDX) | 0.4 | $6.7M | 198k | 33.93 | |
| Dyne Therapeutics (DYN) | 0.3 | $5.0M | 441k | 11.25 | |
| Nextcure (NXTC) | 0.3 | $4.8M | 2.7M | 1.80 | |
| Nucana Sponsored Adr | 0.3 | $4.4M | 5.6M | 0.79 | |
| Fibrogen Put Option | 0.3 | $4.2M | 1.5M | 2.70 | |
| Bolt Biotherapeutics | 0.2 | $3.5M | 2.8M | 1.28 | |
| Nucana Common Shares | 0.1 | $1.9M | 2.4M | 0.79 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $718k | 143k | 5.03 | |
| Fusion Pharmaceuticals | 0.0 | $547k | 117k | 4.67 | |
| Savara (SVRA) | 0.0 | $308k | 96k | 3.19 | |
| Allakos | 0.0 | $272k | 63k | 4.36 | |
| Synlogic | 0.0 | $247k | 575k | 0.43 | |
| Mirum Pharmaceuticals (MIRM) | 0.0 | $235k | 9.1k | 25.87 | |
| Spruce Biosciences (SPRB) | 0.0 | $125k | 58k | 2.15 |
